HK1 and neoplasm: The glycolytic enzyme ENO1 is reported to be overexpressed in cancer and inflammatory cells and this promotes glycolysis, activates signalling pathways important in cancer including PI3K/AKT/mTOR, and drives tumor migration, invasion, and metastasis [33, 34].